RecruitingNCT02545478
Biomarkers in Infection
Early Detection of Inflammatory Biomarkers in Infection
Sponsor
Beth Israel Deaconess Medical Center
Enrollment
4,200 participants
Start Date
Apr 1, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Eligibility
Min Age: 18 Years
Inclusion Criteria8
- Age 18 years of age or older
- Confirmed or suspected infection
- Age 18 years of age or older
- A non-infectious clinical presentation to include
- Normal white blood cell count ( > 4,000 and/or < 12,000)
- Normothermia ( > 96.5 and/or less 100.4)
- Absence of the following clinical complaints: productive cough, fever, pyuria, rash
- No evidence of acute coronary syndrome
Exclusion Criteria1
- \- Suspected infection
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02545478
Related Trials
Diagnosis and Management of Inflammatory and Infectious Diseases
NCT005577261 location
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
NCT069811693 locations
Stop Sepsis Through Home Monitoring Cooperative
NCT069209791 location
Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia
NCT071987891 location
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NCT065628031 location